Cargando…
The Role of Type 2 Inflammation in Schistosoma-Induced Pulmonary Hypertension
Approximately 5% of individuals chronically infected with Schistosoma mansoni develop pulmonary hypertension (PH). The disease is progressive and often fatal, and treatment options are palliative, not curative. Recent studies have unraveled major players of the Th2 inflammation axis in the Schistoso...
Autores principales: | Mickael, Claudia S., Graham, Brian B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353826/ https://www.ncbi.nlm.nih.gov/pubmed/30733718 http://dx.doi.org/10.3389/fimmu.2019.00027 |
Ejemplares similares
-
Experimental Schistosoma japonicum-induced pulmonary hypertension
por: Kassa, Biruk, et al.
Publicado: (2022) -
Paclitaxel blocks Th2-mediated TGF-β activation in
Schistosoma mansoni-induced pulmonary
hypertension
por: Kassa, Biruk, et al.
Publicado: (2018) -
Th2 CD4(+) T Cells Are Necessary and Sufficient for Schistosoma‐Pulmonary Hypertension
por: Kumar, Rahul, et al.
Publicado: (2019) -
Repetitive schistosoma exposure causes perivascular lung fibrosis and persistent pulmonary hypertension
por: Kumar, Rahul, et al.
Publicado: (2023) -
Schistosomiasis Pulmonary Arterial Hypertension
por: Sibomana, Jean Pierre, et al.
Publicado: (2020)